NCT04689399View on ClinicalTrials.gov

Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test

NACompletedINTERVENTIONAL
Enrollment

4,697

Participants

Timeline

Start Date

December 26, 2020

Primary Completion Date

March 25, 2021

Study Completion Date

March 25, 2021

Conditions
Covid19Rapid Antigen TestSARS-CoV-2
Interventions
DIAGNOSTIC_TEST

Standard Q COVID-19 Ag - test, produced by SD Biosensor INC.

Alle Danish citizens tested for infection with SARS-CoV-2 by swabs in the oropharynx, and subsequently analysis of the specimens by RT-PCR test at Testcenter Danmark's test centers will be included in the study. Participants will, in addition to the oropharyngeal swab they are already schedule for, be examined by a rapid antigen test.

Trial Locations (1)

2100

Christian von Buchwald, MD, DMSc, Professor, Copenhagen

All Listed Sponsors
collaborator

Testcenter Danmark, Statens Serum Institut

UNKNOWN

collaborator

Copenhagen Emergency Medical Services

UNKNOWN

lead

Rigshospitalet, Denmark

OTHER

NCT04689399 - Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test | Biotech Hunter | Biotech Hunter